Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease.
about
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel diseaseMucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.Genetic variants associated with Crohn's diseaseStopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy?Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease.Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy.New Insights into the Mechanisms of Action of Anti-Tumor Necrosis Factor-α Monoclonal Antibodies in Inflammatory Bowel Disease.Transcriptome profiling of mouse colonic eosinophils reveals a key role for eosinophils in the induction of s100a8 and s100a9 in mucosal healing.The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.Practical Approaches to "Top-Down" Therapies for Crohn's Disease.Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα-blocking agents.Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis.Pharmacogenetics of inflammatory bowel disease.European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ('Exit Strategies') in Inflammatory Bowel Disease.Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study.Anti-TNF Withdrawal in Inflammatory Bowel Disease.Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy
P2860
Q26866281-9FE68BC2-4BE9-4C3F-8FC1-E6E62D4E8739Q36578893-7552EB04-9109-4083-AF1D-354CAB0CF88BQ37074271-A6A2C765-4CA7-4E7D-9CD6-406172E56D03Q38191334-0172E5E1-B091-4369-91DB-9601F956F914Q38293774-BB179CD5-1EC1-417F-852B-C90091652034Q38527999-D4D5D1B9-6C1E-414B-BB8E-590B0A20E875Q38582765-24599099-1E8F-45FD-B7F8-D127CAE76E07Q38645859-10B2E8C3-5FCD-4AFA-8C3F-BBF515D9D59CQ38784697-BF23FD2A-5E30-45AD-96B8-124C52A87F00Q38835478-DA1F7D4E-5312-4A86-9256-9CAFC57091B2Q39223252-16676715-40E2-4A72-936C-5CDFA5D85F9AQ41475075-42F185C8-8C4C-4FA1-AD13-21D0536D2015Q41673937-C82A4B53-D17D-4986-A620-6F5EB539969AQ41990807-C3CA56F7-F0FD-4BA0-BA59-9E9BFCF647CFQ45633314-ACCA8650-53FE-41CB-AE03-8280542706A1Q55421713-538A9AE7-5E44-40DF-B2BF-7AA22B673C6BQ57239820-B4323978-98AE-4137-B73A-B0A3B930F7EF
P2860
Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Normalization of mucosal cytok ...... NF therapy in Crohn's disease.
@en
Normalization of mucosal cytok ...... NF therapy in Crohn's disease.
@nl
type
label
Normalization of mucosal cytok ...... NF therapy in Crohn's disease.
@en
Normalization of mucosal cytok ...... NF therapy in Crohn's disease.
@nl
prefLabel
Normalization of mucosal cytok ...... NF therapy in Crohn's disease.
@en
Normalization of mucosal cytok ...... NF therapy in Crohn's disease.
@nl
P2093
P2860
P1476
Normalization of mucosal cytok ...... NF therapy in Crohn's disease.
@en
P2093
Eyvind J Paulssen
Guanglin Cui
Ingrid Christiansen
Jon Florholmen
Knut Johnsen
Renathe Rismo
Trine Olsen
P2860
P304
P356
10.3109/00365521.2012.758773
P50
P577
2013-01-10T00:00:00Z